Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) ("Sage" or "the Company"), today announced that its Board of Directors has initiated a process to explore strategic alternatives for the Company. The Board ...

After decades of practising psychotherapy, I believe it has little foundation in science and often causes harm ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The owner of Sage Screen Printing Studio shares how he started "West Wing" a Ravens fan group in Los Angeles.

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...

Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have been assigned a consensus rating of “Hold” from the ...

Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...

Some of the healthy habits include ... Also read | Iron buildup in your brain can increase dementia risk! This diet can help According to a study published in the Sage Journal, a set of ...